An analysis of data from Denmark finds no associated increased risk of major birth defects for mothers who were exposed during the first trimester of pregnancy to the antiviral drugs acyclovir, valacyclovir and famciclovir, often used to treat herpes simplex and herpes zoster infections, according to a new study.